Extracellular matrix grafts for the treatment of volumetric muscle loss
Extracellular matrix grafts for the treatment of volumetric muscle loss
批准号:
577534-2022
负责人:
Bentzinger, FlorianCF
金额:
$3.28万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Musculoskeletal injuries are one of the most frequent reasons for emergency room visits and make up over 75% of battlefield wounds in modern combat. Skeletal muscle, one of the most abundant tissues of the human body, has a remarkable regenerative capacity mediated by tissue resident myogenic progenitors (MPs). However, MPs require an extracellular matrix (ECM) template to efficiently repair damaged muscle tissue. Volumetric muscle loss (VML) is caused by excision of large portions of skeletal muscle as a consequence of injuries or surgery. Due to the absence of an organized ECM and their limited migratory capacity, MPs in unaffected areas of skeletal muscle adjacent to the injury fail to efficiently repopulate and repair the VML site. As a result, VML frequently results in chronic functional deficits and disability that have a considerable socioeconomic impact. Over the recent years we have developed sophisticated methods for decellularization of skeletal muscle tissue. By providing guidance cues for endogenous MPs, these ECM scaffolds hold great therapeutic promise as grafts for VML injuries. Here, we assembled an interdisciplinary team of bioengineers and stem cell biologists to develop a microfabricated polysulfone cell culture chamber system to assess the ability of MPs to migrate into and repopulate fibrin gel embedded ECM scaffolds. These experiments will, for the first time, provide an in-vitro platform to assess the potential of ECM scaffold preparations as grafts for VML injuries. In parallel experiments, we will test the efficiency of our decellularized fibrin embedded skeletal muscle ECM scaffolds to promote the repair of VML injuries in mice. Lastly, in a third, partially interdependent aim, we will test a library of previously identified and novel pro-migratory growth factors for their ability to stimulate the recellularization of ECM scaffolds in our in-vitro system and subsequently in our mouse model of VML. Ultimately, our work will inspire the development of much needed novel therapeutic avenues for the treatment of VML. A surgical intervention that is capable to enhance the repair of VML injuries represents an opportunity to ease the burdens of daily living for thousands of patients each year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
基于Matrix2000加速器的个性小数据在线挖掘
-
批准号:2020JJ4669
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:甘新标
-
依托单位:
细胞重编程过程中的细胞通讯和命运决定机制研究
-
批准号:U20A2013
-
项目类别:联合基金项目
-
资助金额:253.0万元
-
批准年份:2020
-
负责人:王涛
-
依托单位:
氧化应激诱导血管发生微环境中Fibronectin组装异常的机制研究
-
批准号:31801174
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2018
-
负责人:乔梁峻
-
依托单位:
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
-
批准号:31760328
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:周建奖
-
依托单位:
基质刚度介导YAP/TAZ信号调控对硬皮病成纤维细胞增殖活化的靶向基质效应研究
-
批准号:81760301
-
项目类别:地区科学基金项目
-
资助金额:32.0万元
-
批准年份:2017
-
负责人:马云青
-
依托单位:
抑制肿瘤转移的新靶点: iPLA2在整合素和基质金属蛋白酶再循环中的新颖作用
-
批准号:31671450
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2016
-
负责人:CHANG YONG CHUNG
-
依托单位:
VEGFR-1/Src/miR-21/MMP-9信号轴调控肝细胞癌侵袭转移的机制研究
-
批准号:81660487
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2016
-
负责人:时军
-
依托单位:
树突状细胞迁移的分子机制及其在RA发病机制中的作用
-
批准号:81471613
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2014
-
负责人:孙尔维
-
依托单位:
毫米波封装系统中高效、高精度的滤波器建模方法研究
-
批准号:61101047
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:王建朋
-
依托单位: